Concepedia
Statistics
Publications
203
Citations
24.7K
H-Index
69
Active since
2004
Affiliations
Dana-Farber Cancer Institute(Current)
Memorial Sloan Kettering Cancer Center
Brigham and Women's Hospital
Foundation Medicine (United States)
Harvard University
Geoffrey R. Oxnard is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and molecular oncology.
Publications per year
2004–2025
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip et al. · Nature Medicine · 2015 · 1.5K citations · Full text
Medicine, Molecular Biology, Oncology +11
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein et al. · Annals of Oncology · 2020 · 1.5K citations · Full text
Medicine, Molecular Biology, Oncology +17
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer
Geoffrey R. Oxnard, Kenneth S. Thress, Ryan S. Alden et al. · Journal of Clinical Oncology · 2016 · 843 citations · Full text
Medicine, Oncology, Pharmacology +17
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan et al. · New England Journal of Medicine · 2020 · 836 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Noninvasive Detection of Response and Resistance in <i>EGFR</i> -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
Geoffrey R. Oxnard, Cloud P. Paweletz, Yanan Kuang et al. · Clinical Cancer Research · 2014 · 782 citations
Medicine, Genetics, Oncology +17
1–5 of 203